BioMedNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Medical Device Certification for IoT-Powered Dry Herb Inhaler, Software

RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received ISO 13485:2016/MDSAP and EN ISO 13485:2016 certification for its proprietary Internet of Things (“IoT”)-powered dry herb inhaler (the “RYAH Smart Inhaler”) and software application associated with the device. According to the update, the certification is a regulatory requirement and an international standard that outlines the requirements for a quality management system specific to the medical devices industry. “This is a monumental achievement for RYAH Group Inc. and its subsidiary, RYAH Medtech Inc., as we continue to reimagine plant-based medicine delivery solutions for doctors, clinics and their patients looking for a safe inhalation device with valuable monitoring capabilities,” said Gregory Wagner, CEO of the company. “The approval of the RYAH Smart Inhaler device along with its accompanying software is one of the first of its kind in plant based inhalation devices. It marks a new era for RYAH Group Inc. and is an example of our commitment to utilize data and digital offerings for enabling customized, personalized therapy regimens as an achievable goal for patients and physicians.”

To view the full press release, visit https://ibn.fm/4EWkU

About RYAH Group Inc.

RYAH is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates Health Insurance Portability and Accountability Act (“HIPAA”)-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and licensed processors (“LPs”) to monitor and manage formulation effects on patients and demographics. With a strong intellectual property portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation lifecycle. For more information, visit www.RYAHGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork